Targeting DNA damage response in head and neck cancers through abrogation of cell cycle checkpoints

AbstractPurpose: Head and neck cancers (HNSCC) are routinely treated with radiotherapy; however normal tissue toxicity remains a concern. Therefore, it is important to validate treatment modalities...